首页> 外文会议>Asian Symposium on Advanced Biomaterials; 20060820-23; Jeju Island(KR) >Supercritical Carbon Dioxide Assisted Impregnation of Molsidomine into Poly(dl-Lactide-co-glycolide) for Sustained Release Applications
【24h】

Supercritical Carbon Dioxide Assisted Impregnation of Molsidomine into Poly(dl-Lactide-co-glycolide) for Sustained Release Applications

机译:超临界二氧化碳辅助将莫西多胺浸渍到聚(dl-丙交酯-共-乙交酯)中,用于缓释应用

获取原文
获取原文并翻译 | 示例

摘要

Supercritical carbon dioxide (scCO_2) was used as a processing medium for the fabrication of drug encapsulated poly(DL-lactide-co-glycolide) (PLGA) monoliths for their potential application in the controlled release of water soluble drugs. Exposure of PLGA to scCO_2 leads to effective plasticization and liquefaction due to the high solubility and interaction of the scCO_2 in the copolymer. By exploiting this property, it was demonstrated that prolonged release formulations of molsidomine, a peripheral nitrovasodilator used to treat angina pectoris, can be prepared by chemical solvent-free, scCO_2 assisted drug impregnation method. The in-vitro dissolution studies revealed that the release rates of drug from the porous polymer monoliths containing different amount of the drug samples were significantly retarded due to encapsulation of molsidomine into the PLGA matrix.
机译:超临界二氧化碳(scCO_2)被用作制备药物封装的聚(DL-丙交酯-共-乙交酯)(PLGA)整体料的加工介质,因为它们潜在地用于控制释放水溶性药物。由于scCO_2在共聚物中的高溶解度和相互作用,因此PLGA暴露于scCO_2会导致有效的增塑和液化。通过利用该性质,证明了可以通过无化学溶剂,scCO_2辅助的药物浸渍方法来制备用于治疗心绞痛的周边硝普血管扩张剂molsidomine的延长释放制剂。体外溶出研究表明,由于将酚精胺封装在PLGA基质中,药物从含有不同量药物样品的多孔聚合物整体中的释放速率显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号